ATUL vs ROSSARI: Stock Comparison
ATUL is the larger company by market capitalisation. ATUL shows a higher dividend yield, lower leverage and a higher net margin, while ROSSARI BIOTECH shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ATUL leads 7; ROSSARI leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ATUL | ROSSARI |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | ATUL | ROSSARI |
|---|---|---|
| Live Price | ₹5,015 | ₹400 |
| Day Change | -2.55% | -1.86% |
| Volume | 15,844 | 18,836 |
| 52-Week High | ₹7,180 | ₹654 |
| 52-Week Low | ₹5,103.5 | ₹375 |
| Distance from 52W High | -30.15% | -38.84% |
Valuation
| Metric | ATUL | ROSSARI |
|---|---|---|
| Market Cap | ₹14,818 Cr | ₹2,233 Cr |
| P/E Ratio | 19.61x | 14.76x |
| P/B Ratio | 2.3x | 1.6x |
| EPS | ₹262.19 | ₹7.02 |
| Book Value | ₹2,235.96 | ₹240.7 |
| Dividend Yield | 0.57% | 0.12% |
Growth
| Metric | ATUL | ROSSARI |
|---|---|---|
| Revenue Growth (TTM YoY) | 15% | 18.2% |
| EPS Growth (TTM YoY) | 66.1% | 33.5% |
| Qtr Sales Growth | 1.57% | 0.05% |
| Qtr Profit Growth | -37.5% | 10.86% |
Profitability & Leverage
| Metric | ATUL | ROSSARI |
|---|---|---|
| ROE | 9.83% | 11.72% |
| ROCE | 9.63% | 11.79% |
| Net Margin | 10.13% | 6.14% |
| Operating Margin | 13.72% | 11.67% |
| Debt to Equity | 0x | 0.1x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | ATUL | ROSSARI |
|---|---|---|
| Promoter Holding | 45.33% | 63.63% |
| FII Holding | 8.9%▲ 1.46 pp | 1.84%▼ 0.18 pp |
| DII Holding | 25.23%▼ 0.7 pp | 14.19%▼ 0.45 pp |
| Public Holding | 20.53%▼ 0.76 pp | 15.83%▲ 0.63 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ATUL and ROSSARI BIOTECH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.